What does CUSIP 427746102 represent in this 13F holders report?

CUSIP 427746102 is the security identifier for HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock used to aggregate holder disclosures.

How many institutions held HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in Q2 2014?

67 institutional investors reported HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock for Q2 2014. Use the holders table for investor-level position and value details.

- Common Stock (HRTX)

CUSIP: 427746102

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class: Equity / Common Stock
Shares outstanding: 182,615,507
Total 13F shares: 26,551,442
Share change: +5,746,372
Total reported value: $327,060,299
Price per share: $12.32
Number of holders: 67
Value change: +$69,901,807
Number of buys: 51
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 427746102?
CUSIP 427746102 identifies HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2014
Previous quarter: Q1 2014

Recent filing periods for CUSIP 427746102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
TANG CAPITAL MANAGEMENT LLC	13F	Company	2.4%	4,408,987	$61,329,000	—	31 Mar 2014	13F
FRANKLIN RESOURCES INC	13F	Company	1.8%	3,251,353	$45,226,000	—	31 Mar 2014	13F
Broadfin Capital, LLC	13F	Company	1.2%	2,233,173	$31,063,000	—	31 Mar 2014	13F
BAKER BROS. ADVISORS LP	13F	Company	1.2%	2,167,784	$30,153,000	—	31 Mar 2014	13F
Savitr Capital, LLC	13F	Company	1%	1,856,761	$25,828,000	—	31 Mar 2014	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.97%	1,762,426	$24,515,000	—	31 Mar 2014	13F
VHCP Management, LLC	13F	Company	0.6%	1,095,734	$15,242,000	—	31 Mar 2014	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.51%	924,231	$12,856,000	—	31 Mar 2014	13F
Tekla Capital Management LLC	13F	Company	0.38%	696,597	$9,690,000	—	31 Mar 2014	13F
FMR LLC	13F	Company	0.27%	487,820	$6,786,000	—	31 Mar 2014	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.2%	373,315	$5,185,000	—	31 Mar 2014	13F
ISZO CAPITAL MANAGEMENT LP	13F	Company	0.19%	347,051	$4,827,000	—	31 Mar 2014	13F
THB ASSET MANAGEMENT	13F	Company	0.1%	181,945	$2,530,000	—	31 Mar 2014	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.09%	172,697	$2,402,000	—	31 Mar 2014	13F
GLG Partners LP	13F	Company	0.07%	126,182	$1,755,000	—	31 Mar 2014	13F
ASCEND CAPITAL, LLC	13F	Company	0.07%	125,663	$1,749,000	—	31 Mar 2014	13F
MORGAN STANLEY	13F	Company	0.06%	116,761	$1,624,000	—	31 Mar 2014	13F
Forward Management, LLC	13F	Company	0.05%	93,014	$1,127,000	—	31 Mar 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.03%	62,243	$865,000	—	31 Mar 2014	13F
Moab Capital Partners LLC	13F	Company	0.03%	55,734	$775,000	—	31 Mar 2014	13F
UBS AG	13F	Company	0.03%	52,176	$726,000	—	31 Mar 2014	13F
JANE STREET GROUP, LLC	13F	Company	0.02%	44,760	$622,000	—	31 Mar 2014	13F
E. E. Geduld	13F	Individual	0.01%	25,000	$348,000	—	31 Mar 2014	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.01%	24,999	$348,000	—	31 Mar 2014	13F
NORTHERN TRUST CORP	13F	Company	0.01%	21,453	$298,000	—	31 Mar 2014	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.01%	16,803	$234,000	—	31 Mar 2014	13F
CREDIT SUISSE AG/	13F	Company	0.01%	16,600	$231,000	—	31 Mar 2014	13F
LMR Partners LLP	13F	Company	0.01%	14,367	$200,000	—	31 Mar 2014	13F
BlueCrest Capital Management LLP	13F	Company	0.01%	13,800	$192,000	—	31 Mar 2014	13F
TFS CAPITAL LLC	13F	Company	0.01%	13,651	$190,000	—	31 Mar 2014	13F
STATE STREET CORP	13F	Company	0.01%	12,400	$173,000	—	31 Mar 2014	13F
DEUTSCHE BANK AG\	13F	Company	0%	3,213	$44,000	—	31 Mar 2014	13F
TradeLink Global Equity LLC	13F	Company	0%	1,200	$17,000	—	31 Mar 2014	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	1,123	$16,000	—	31 Mar 2014	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0%	580	$8,000	—	31 Mar 2014	13F
COLONY GROUP LLC	13F	Company	0%	143	$2,000	—	31 Mar 2014	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	120	$1,669	—	31 Mar 2014	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	100	$1,000	—	31 Mar 2014	13F
CITIGROUP INC	13F	Company	0%	69	$1,000	—	31 Mar 2014	13F
Winslow, Evans & Crocker, Inc.	13F	Company	0%	1	$14	—	31 Mar 2014	13F

Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q2 2014

As of 30 Jun 2014, HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,551,442 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, Savitr Capital, LLC, PERCEPTIVE ADVISORS LLC, VHCP Management, LLC, Tekla Capital Management LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, and Cormorant Asset Management, LLC. This page lists 67 institutional shareholders reporting positions in this security for the Q2 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2014 vs Q1 2014 Across Filers

Q1 2014 holders

Q2 2014 holders

Holder diff

Investor	Q1 2014 Shares	Q2 2014 Shares	Share Diff	Share Chg %	Q1 2014 Value $	Q2 2014 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.